Waisman Biomanufacturing, strategically affiliated with the University of Wisconsin-Madison, is a renowned provider of contract manufacturing services, specialising in the production of biologics for human clinical trials. The company possesses extensive expertise in manufacturing a diverse array of biologics including plasmid DNA, cell therapeutics, viral vectors, vaccines, and recombinant proteins. Serving both internal and external partners across biotech, non-profit, and academic sectors, Waisman Biomanufacturing is committed to advancing the development of innovative therapies.

Services include:
– Biologics
– Cell and Gene Therapy
– Drug Substance Manufacturing (API)
– Drug Product Formulation (FDF)
– Analytical Methods Development

Waisman Biomanufacturing stands as a pivotal entity within the pharmaceutical industry, consistently delivering high-quality manufacturing solutions tailored to meet the needs of its partners. For further details, please visit gmpbio.org.